EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 73 filers reported holding EVELO BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $99 | -99.9% | 61,289 | 0.0% | 0.00% | – |
Q3 2022 | $128,000 | -0.8% | 61,289 | 0.0% | 0.00% | – |
Q2 2022 | $129,000 | -38.0% | 61,289 | 0.0% | 0.00% | – |
Q1 2022 | $208,000 | -44.1% | 61,289 | 0.0% | 0.00% | -100.0% |
Q4 2021 | $372,000 | -13.7% | 61,289 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $431,000 | – | 61,289 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 18,233,403 | $215,154,000 | 41.21% |
HARBOURVEST PARTNERS LLC | 1,763,505 | $20,809,000 | 26.29% |
Alphabet Inc. | 1,060,495 | $12,514,000 | 1.05% |
SECTORAL ASSET MANAGEMENT INC | 437,500 | $5,163,000 | 0.58% |
DC Investments Management, LLC | 36,924 | $436,000 | 0.28% |
ARK Investment Management | 126,831 | $1,497,000 | 0.06% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 22,998 | $271,000 | 0.03% |
Laurion Capital Management LP | 150,000 | $1,770,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 9,380 | $111,000 | 0.01% |
CREDIT SUISSE AG/ | 440,169 | $5,194,000 | 0.01% |